In skeletal muscle, ERRα/γ enhanced oxidative capacity [34,35,51,54,[66], [67], [68]], and Mootha et al. have proposed that ERRα agonism may offset the molecular implications of skeletal muscle insulin resistance in patients living with type 2 diabetes [42]. This evidence concerns the gene INS and type 2 diabetes mellitus.